Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
162 Leser
Artikel bewerten:
(0)

Nestle Health Science and Moog announce North American exclusive distribution agreement for EnteraLite Infinity Pump

New agreement expands access to state-of-the-art enteral delivery systems for hospital and home care patients

FLORHAM PARK, N.J., Feb. 22, 2013 /PRNewswire-USNewswire/ -- Nestle Health Science and Moog, Inc. announced today that effective immediately Nestle Health Science will become the exclusive distributor in the U.S. and Canada for Moog's EnteraLite® Infinity® Pump, including compatible administration sets and accessories. The EnteraLite® Infinity® Pump is regarded as one of the leading enteral (tube feeding) delivery systems in the North American market. The agreement between Nestle Health Science and Moog expands availability of a state-of-the-art enteral delivery system that can be used across the full continuum of care - for adult and pediatric patients in the hospital and at home. Working together, both companies are now well positioned to meet the needs of hospital, home care and other alternate site customers.

"We are very pleased to enter into this agreement with Moog so that we can offer an innovative product like the EnteraLite® Infinity® Pump through the strength of our established Sales Force in the U.S. and Canada," said David Yates, North American Region Head for the HealthCare Nutrition business within Nestle Health Science. "We see this agreement as an important part of our plan to fulfill the Nestle Health Science mission of Nourishing Personal Health by delivering innovative, patient centric nutritional solutions. With this agreement in place, Nestle Health Science offers the most comprehensive array of science-based nutritional formulas, enteral delivery systems and feeding tubes available in North America."

"The relationship between Nestle Health Science and Moog Medical Devices Group is an extremely important combination of the best that can be offered in the marketplace," said Martin Berardi, President, Moog Medical Devices Group. "Our relationship has developed into one where trust and cooperation is the main ingredient which will provide excellent outcomes today and also into the future."

The terms of this agreement are not being disclosed.

About Nestle Health Science
Nestle Health Science was formed in January 2011 to spearhead the development of science-based personalized nutritional solutions. Building on its core HealthCare Nutrition business, the company has ambitions to address chronic conditions in the area of Gastrointestinal Health, Metabolic Health and Brain Health. Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the special challenges of different life stages. Nestle Health Science is a wholly owned subsidiary of Nestle S.A., with worldwide headquarters in Lutry, Switzerland. Additional information can be found at www.nestlehealthscience.us.

About Moog Medical Devices
Moog Medical Devices, part of Moog Inc. (NYSE: MOG.A and MOG.B), supports intravenous (IV) therapy and enteral nutrition delivery with a suite of pumps, fluid delivery systems and components. Moog Inc. is a worldwide designer, manufacturer, and integrator of precision control components and systems. Additional information about the Company can be found at www.moog.com.

200392 Rev A

SOURCE Nestle Health Science

© 2013 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.